Wei-Wu He insider trades: CASI Pharmaceuticals (CASI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Wei-Wu reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | CASI | ↑ Buy | 88,154 | $3.09 | $273K | Direct | Jun 17, 2022 (2d) |
| Nov 18, 2021 | CASI | ↑ Buy | 400,000 | $0.98 | $394K | Direct | Nov 19, 2021 (1d) |
| Aug 19, 2021 | CASI | ↑ Buy | 480,000 | $1.28 | $614K | Direct | Aug 20, 2021 (1d) |
| Mar 26, 2021 | CASI | ↑ Buy | 3,000,000 | $2.05 | $6.1M | Indirect | Mar 30, 2021 (4d) |
| Nov 23, 2020 | CASI | ↑ Buy | 227,471 | $2.15 | $488K | Direct | Nov 24, 2020 (1d) |
| Jul 22, 2020 | CASI | ↑ Buy | 2,952,426 | $1.90 | $5.6M | Direct | Jul 24, 2020 (2d) |
| Jul 22, 2020 | CASI | ↑ Buy | 1,200,000 | $1.90 | $2.3M | Indirect | Jul 24, 2020 (2d) |
| May 20, 2020 | CASI | ↑ Buy | 86,265 | $2.25 | $194K | Direct | May 21, 2020 (1d) |
| May 18, 2020 | CASI | ↑ Buy | 438,932 | $1.97 | $867K | Direct | May 19, 2020 (1d) |
| Mar 27, 2020 | CASI | ↑ Buy | 6,880 | $2.08 | $14K | Direct | Mar 30, 2020 (3d) |
| Mar 26, 2020 | CASI | ↑ Buy | 524,493 | $2.03 | $1.1M | Direct | Mar 27, 2020 (1d) |
| Mar 19, 2020 | CASI | ↑ Buy | 1,000,002 | $1.53 | $1.5M | Indirect | Mar 19, 2020 (0d) |
| Aug 16, 2019 | CASI | ↑ Buy | 20,000 | $3.20 | $64K | Direct | Aug 20, 2019 (4d) |
| Aug 14, 2019 | CASI | ↑ Buy | 160,000 | $3.17 | $507K | Direct | Aug 15, 2019 (1d) |
| Mar 19, 2018 | CASI | ↑ Buy | 3,086,419 | $3.24 | $10.0M | Indirect | Mar 21, 2018 (2d) |
| Oct 10, 2017 | CASI | ↑ Buy | 100,000 | $1.95 | $195K | Direct | Oct 11, 2017 (1d) |
| Oct 6, 2017 | CASI | ↑ Buy | 200,000 | $1.83 | $366K | Direct | Oct 10, 2017 (4d) |
| Sep 19, 2017 | CASI | ↑ Buy | 207,502 | $1.75 | $364K | Direct | Sep 20, 2017 (1d) |
| Sep 15, 2017 | CASI | ↑ Buy | 315,327 | $1.33 | $419K | Direct | Sep 18, 2017 (3d) |
| Oct 3, 2016 | CASI | ↑ Buy | 1,871,605 | $1.19 | $2.2M | Indirect | Oct 5, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Wei-Wu He's insider trades
Wei-Wu He is Chairman and CEO at CASI Pharmaceuticals (CASI). Since Oct 3, 2016, Wei-Wu has reported 20 open-market purchases worth $33.6M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), gifts (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CASI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.